Skip to Main Content

Paper Details

Efficacy and feasibility of ruxolitinib in chronic steroid-refractory GVHD in a pediatric intestine transplant.
Pediatric Transplantation
7
2021
Acute graft-versus-host disease, GVHD, GvHD, JAK 1/2, SR, SR-GVHD, child, patient, patients, ruxolitinib, skin rash
Author NameAffiliation
Nada YazigiTransplant Institute, MedStar Georgetown University Hospital
Stuart S KaufmanTransplant Institute, MedStar Georgetown University Hospital
Thomas M FishbeinTransplant Institute, MedStar Georgetown University Hospital
Alexander KroemerTransplant Institute, MedStar Georgetown University Hospital
Khalid Mohammed KhanTransplant Institute, MedStar Georgetown University Hospital
  • 1 - 5

Datasets

Release 1.2